Cargando…
NLRP3 Inflammasome Inhibition: A Potential Therapeutic Strategy to Attenuate Postinfarction Adverse Cardiac Remodeling
[Figure: see text]
Autores principales: | Narendran, Siddharth, Pereira, Felipe, Ambati, Jayakrishna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775956/ https://www.ncbi.nlm.nih.gov/pubmed/33427823 http://dx.doi.org/10.1016/j.jacbts.2020.11.004 |
Ejemplares similares
-
Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial Infarction
por: Louwe, Mieke C., et al.
Publicado: (2020) -
Noise exposure and its relationship with postinfarction cardiac remodeling: implications for NLRP3 inflammasome activation
por: Wei, Yanzhao, et al.
Publicado: (2022) -
The Role of NLRP3 Inflammasome in Pericarditis: Potential for Therapeutic Approaches
por: Mauro, Adolfo G., et al.
Publicado: (2021) -
Micronized Acellular Matrix Biomaterial Leverages Eosinophils for Postinfarct Cardiac Repair
por: Vasanthan, Vishnu, et al.
Publicado: (2023) -
Taurine Alleviates Sympathetic Innervation by Inhibiting NLRP3 Inflammasome in Postinfarcted Rats
por: Lee, Cheng-Che, et al.
Publicado: (2021)